HIP ATTACK-2 is a multi-center, international, randomized controlled trial to determine whether accelerated surgery for hip fracture in patients with acute myocardial injury is superior to standard care in reducing death at 90 days after randomization. Other outcomes include; inability to walk 3 meters independently, time to standing and weight-bearing, delirium, length of stay, pain, and quality of life.
Patient Stories
July 2, 2024
Connor Anderson shares his journey from living kidney donor at Tufts Medical Center to Boston Marathon runner.